Elevation Oncology, Inc. Contracts & Agreements
30 Contracts & Agreements
- Business Finance (13 contracts)
- Business Operations (3)
- Human Resources (9)
- Intellectual Property (2)
- Uncategorized (3)
- Form of Change in Control and Severance Agreement (Filed With SEC on August 6, 2024)
- Warrant to Purchase Common Stock, issued March 1, 2024, to K2 HealthVentures Equity Trust LLC (Filed With SEC on May 2, 2024)
- First Amendment to Loan and Security Agreement, dated March 1, 2024, by and among the Company, the lenders, and K2 HealthVentures LLC, as administrative agent (Filed With SEC on May 2, 2024)
- Employment Agreement dated July 12, 2023 by and between the Registrant and Joseph J. Ferra, Jr (Filed With SEC on November 2, 2023)
- Employment Agreement dated July 12, 2023 by and between the Registrant and Tammy Furlong (Filed With SEC on November 2, 2023)
- Underwriting Agreement dated June 8, 2023 (Filed With SEC on June 9, 2023)
- Form of Purchase Warrant (Filed With SEC on June 9, 2023)
- Form of Pre-Funded Warrant (Filed With SEC on June 9, 2023)
- Separation Agreement, dated January 5, 2023, between the Company and Shawn M. Leland (Filed With SEC on May 15, 2023)
- Offer Letter dated March 16, 2022, by and between the Registrant and David Dornan (Filed With SEC on March 9, 2023)
- Warrant to Purchase Common Stock, issued July 27, 2022 to K2 HealthVentures Equity Trust LLC (Filed With SEC on November 3, 2022)
- Loan and Security Agreement, dated July 27, 2022, by and among the Company, the lenders, K2 HealthVentures LLC, as administrative agent, and Ankura Trust Company, LLC, as... (Filed With SEC on November 3, 2022)
- License Agreement, dated July 27, 2022, by and between the Company and CSPC Megalith Biopharmaceutical Co., Ltd (Filed With SEC on November 3, 2022)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 3, 2022)
- Employment Agreement dated February 2, 2021 by and between Elevation Oncology, Inc. and Valerie Malyvanh Jansen, as amended (Filed With SEC on March 3, 2022)
- Collaboration Agreement dated June 14, 2021, between Caris MPI, Inc. and Elevation Oncology, Inc (Filed With SEC on June 23, 2021)
- Form of Underwriting Agreement (Filed With SEC on June 21, 2021)
- Form of Common Stock Certificate (Filed With SEC on June 21, 2021)
- Form of Indemnity Agreement (Filed With SEC on June 21, 2021)
- 2021 Equity Incentive Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on June 21, 2021)
- 2021 Employee Stock Purchase Plan, to become effective on the date the registration statement is declared effective, and forms of award agreements (Filed With SEC on June 21, 2021)
- Employment Agreement dated July 12, 2019 by and between Elevation Oncology, Inc. and Shawn Leland, as amended (Filed With SEC on June 21, 2021)
- Employment Agreement dated June 6, 2021 by and between Elevation Oncology, Inc. and Joseph J. Ferra, Jr (Filed With SEC on June 21, 2021)
- Collaboration Agreement dated June 14, 2021, between Caris MPI, Inc. and Elevation Oncology, Inc (Filed With SEC on June 16, 2021)
- Amended and Restated Investors Rights Agreement, dated November 10, 2020 by and among Elevation Oncology, Inc. and certain of its stockholders (Filed With SEC on June 4, 2021)
- 2019 Equity Incentive Plan, as amended, and forms of award agreements (Filed With SEC on June 4, 2021)
- Asset Purchase Agreement dated May 28, 2019, by and between the Registrant and Merrimack Pharmaceuticals, Inc., as amended (Filed With SEC on June 4, 2021)
- Amended and Restated Collaboration Agreement dated January 24, 2007 between Dyax Corp. and Merrimack Pharmaceuticals, Inc., as amended (Filed With SEC on June 4, 2021)
- Commercial License Agreement dated June 4, 2008 between Selexis SA and Merrimack Pharmaceuticals, Inc (Filed With SEC on June 4, 2021)
- Form of IPO Participation Right Letter (Filed With SEC on June 4, 2021)
